1
Total investments
1
Early stage
0
Mid stage
0
Late stage
2y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Strategic Contributor
Feb 2024
Longlive is a health-tech company building AI-driven solutions that improve clinical decision-making, early intervention and preventative health at scale. We operate at the intersection of life sciences, med-tech and digital health, transforming how clinicians and individuals access clarity, confidence and personalised guidance.
Our mission is to close critical gaps in care pathways — from compression therapy to chronic disease prevention — by combining intelligent data, clinical insight and wearable technology into tools that support safer, earlier and more consistent decision-making.
Our flagship innovation is the AI-Guided Clinical Compression Assistant, designed to help non-specialist clinicians start safe, guideline-aligned compression therapy in under two minutes. This addresses a long-standing clinical need, where up to 80% of eligible patients never receive appropriate compression in primary care due to uncertainty and lack of confidence. By reducing this friction, we aim to improve healing outcomes while supporting more consistent utilisation of evidence-based therapy across venous, oedema and wound-care pathways.
Alongside our clinical AI work, the Longlive platform supports preventative health and corporate wellbeing through intelligent insights derived from wearable data, personalised coaching, early risk detection and behaviour-change support. Our broader goal is to empower individuals and organisations with tools that promote healthier lives and reduce avoidable healthcare burden.
We are guided by a simple principle:
technology should enable better decisions — for clinicians, for patients, and for and for the health systems that serve them.
If youre exploring advancements in clinical decision support, wound care innovation, preventative health or digital transformation, we’d love to connect.
Experience · 2 entries
All (2)
Investments (1)
Founder (1)
2025
Founder/ CEO
Sep 2025
Equilinq was created with one of Tencents founders to bridge the gap between European SMEs and China’s world-class manufacturing ecosystem.
After experiencing the challenges of cross-border sourcing firsthand, our Amsterdam-based founders set out to build a platform that makes high-quality, reliable supply chain execution accessible, predictable, and transparent.
Today, Equilinq operates in close partnership with StarIT Group, a Shenzhen-based technology and operations platform founded by one of Tencent’s early co-founders, giving our clients direct access to on-the-ground sourcing, quality control, customization, and logistics in China.
Equilinq is a next-generation sourcing and procurement platform for brands that demand quality, speed, and control. We bring together direct factory sourcing, rigorous QC, custom branding, and global fulfillment into one streamlined system.
With low minimums, transparent pricing, and dedicated multi-language support, we enable brands to test faster, scale confidently, and deliver globally without hidden fees or unnecessary markups.
2024
Investor & Strategic Contributor
Feb 2024
Longlive is a health-tech company building AI-driven solutions that improve clinical decision-making, early intervention and preventative health at scale. We operate at the intersection of life sciences, med-tech and digital health, transforming how clinicians and individuals access clarity, confidence and personalised guidance.
Our mission is to close critical gaps in care pathways — from compression therapy to chronic disease prevention — by combining intelligent data, clinical insight and wearable technology into tools that support safer, earlier and more consistent decision-making.
Our flagship innovation is the AI-Guided Clinical Compression Assistant, designed to help non-specialist clinicians start safe, guideline-aligned compression therapy in under two minutes. This addresses a long-standing clinical need, where up to 80% of eligible patients never receive appropriate compression in primary care due to uncertainty and lack of confidence. By reducing this friction, we aim to improve healing outcomes while supporting more consistent utilisation of evidence-based therapy across venous, oedema and wound-care pathways.
Alongside our clinical AI work, the Longlive platform supports preventative health and corporate wellbeing through intelligent insights derived from wearable data, personalised coaching, early risk detection and behaviour-change support. Our broader goal is to empower individuals and organisations with tools that promote healthier lives and reduce avoidable healthcare burden.
We are guided by a simple principle:
technology should enable better decisions — for clinicians, for patients, and for and for the health systems that serve them.
If youre exploring advancements in clinical decision support, wound care innovation, preventative health or digital transformation, we’d love to connect.
